Cite
APA Citation
Fenaux, P., Santini, V., Komrokji, R. S., Zeidan, A., Garcia-Manero, G., Buckstein, R., Miteva, D., Keeperman, K., Holot, N., Zhang, J., Nadal, J. A., Rosettani, B., Yucel, A., & Platzbecker, U. (n.d.). p778: LONG-TERM UTILIZATION AND BENEFIT OF LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) FROM THE MEDALIST TRIAL. HemaSphere, 6, 673–674. http://access.bl.uk/ark:/81055/vdc_100159756984.0x000012